Norfloxacin-induced toxic epidermal necrolysis
dc.contributor.author | Sahin M.T. | |
dc.contributor.author | Ozturkcan S. | |
dc.contributor.author | Inanir I. | |
dc.contributor.author | Filiz E.E. | |
dc.date.accessioned | 2024-07-22T08:24:03Z | |
dc.date.available | 2024-07-22T08:24:03Z | |
dc.date.issued | 2005 | |
dc.description.abstract | OBJECTIVE: To report a case of toxic epidermal necrolysis (TEN) in a man who was treated with oral norfloxacin for prostatitis. CASE SUMMARY: A 40-year-old man presented with a severe skin reaction, which was diagnosed as TEN. He had received norfloxacin 800 mg/day over a 14-day period for prostatitis and, 10 days after finishing the treatment regimen, he developed cutaneous and mucous lesions typical of TEN. After a prolonged hospitalization and treatment with oral prednisolone therapy, fluid resuscitation, and wound dressing, the man recovered. DISCUSSION: TEN is an infrequent, yet often fatal, severe systemic and cutaneous disease that is most often an adverse drug reaction. There are few case reports of TEN induced by fluoroquinolones. A MEDLINE search (1966-February 2005) revealed no reports of toxic epidermal necrolysis, but one incidence of Stevens-Johnson syndrome due to norfloxacin therapy. An objective causality assessment suggests that TEN was probably related to norfloxacin in this patient. CONCLUSIONS: To our knowledge, this is the first case of TEN associated with the use of oral norfloxacin. We hope that this case report creates awareness that norfloxacin-induced TEN is possible. | |
dc.identifier.DOI-ID | 10.1345/aph.1E530 | |
dc.identifier.issn | 10600280 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/19803 | |
dc.language.iso | English | |
dc.subject | Adult | |
dc.subject | Epidermal Necrolysis, Toxic | |
dc.subject | Humans | |
dc.subject | Male | |
dc.subject | Norfloxacin | |
dc.subject | albumin | |
dc.subject | immunoglobulin | |
dc.subject | norfloxacin | |
dc.subject | prednisolone | |
dc.subject | quinolone derivative | |
dc.subject | Ringer lactate solution | |
dc.subject | adult | |
dc.subject | article | |
dc.subject | blister | |
dc.subject | case report | |
dc.subject | conjunctival hyperemia | |
dc.subject | convalescence | |
dc.subject | disease severity | |
dc.subject | edema | |
dc.subject | erythema | |
dc.subject | eye burning | |
dc.subject | eyelid disease | |
dc.subject | fluid therapy | |
dc.subject | hospitalization | |
dc.subject | human | |
dc.subject | keratitis | |
dc.subject | laboratory test | |
dc.subject | male | |
dc.subject | mouth lesion | |
dc.subject | physical examination | |
dc.subject | priority journal | |
dc.subject | prostatitis | |
dc.subject | resuscitation | |
dc.subject | side effect | |
dc.subject | skin defect | |
dc.subject | skin manifestation | |
dc.subject | toxic epidermal necrolysis | |
dc.subject | wound dressing | |
dc.title | Norfloxacin-induced toxic epidermal necrolysis | |
dc.type | Article |